首页> 美国卫生研究院文献>Cancers >Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation
【2h】

Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation

机译:骨巨细胞肿瘤的晚期局部复发与恶性转化风险增加相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In giant cell tumor of bone (GCTB), an intermediate malignant bone tumor, approximately 4% of cases can undergo malignant transformation. We analyzed risk factors for malignant transformation of GCTB treated without radiotherapy and retrospectively reviewed medical files of 461 patients with GCTB of the extremities who had undergone surgery alone, with no radiotherapy or denosumab therapy. Malignant transformation occurred in 15 of 461 patients (3.3%) at a median follow-up period of 192 months. The median follow-up duration was 89.4 months. Multivariate analysis revealed that local recurrence was an independent prognostic factor for unfavorable malignant transformation. The interval between the last surgery to local recurrence and malignant transformation was longer than that to local recurrence of benign GCTB, with a median of 15.2 (IQR, 5.2–25.4) years versus 1.3 (IQR, 0.8–2.6) months, respectively (p < 0.001). Late local recurrence of GCTB is associated with a higher risk of malignant transformation.
机译:在骨髓肿瘤(GCTB)中,中间恶性骨肿瘤,约4%的病例可以进行恶性转化。我们分析了无放射治疗的GCTB恶性转化的危险因素,并回顾性地审查了461名患有461名患者的医学档,该患者单独经历手术,没有放射治疗或Denosumab治疗。在192个月的中位随访期间,在461名患者中的15个(3.3%)中发生恶性转化。中位后续时间为89.4个月。多变量分析显示,局部复发是不利的恶性转化的独立预后因素。最后一次手术与地方复发和恶性转化之间的间隔比良性GCTB的局部复发,中位数为15.2(IQR,5.2-25.4)岁,分别为1.3(IQR,0.8-2.6)个月(P <0.001)。 GCTB的晚期局部复发与更高的恶性转化风险更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号